Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents
US9840477B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 6, 2016 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Jun 6, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel cyclopropanecarboxamido-substituted aromatic compounds that inhibit protein kinases and their use in anti-tumor area. In particular, the disclosure relates to novel tyrosine-kinase inhibitors and Raf-kinase inhibitors as anti-tumor agents, their preparation, pharmaceutical composition, and their use in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.